Description
Notes:
Sales, means the sales volume of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Revenue, means the sales value of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
This report studies sales (consumption) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Creatv MicroTech
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
Aviva Biosciences Corporation
ScreenCell
Silicon Biosystems
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
CellSearch
Other
Type III
Split by application, this report focuses on sales, market share and growth rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in each application, can be divided into
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
Table of contents
Table of Contents
Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2016
1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Overview
  1.1 Product Overview and Scope of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
  1.2 Classification of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
     1.2.1 CellSearch
     1.2.2 Other
     1.2.3 Type III
  1.3 Application of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
     1.3.1 Breast Cancer Diagnosis and Treatment
     1.3.2 Prostate Cancer Diagnosis and Treatment
     1.3.3 Colorectal Cancer Diagnosis and Treatment
     1.3.4 Lung Cancer Diagnosis and Treatment
     1.3.5 Other Cancers Diagnosis and Treatment
  1.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Countries
     1.4.1 Germany Status and Prospect (2011-2021)
     1.4.2 France Status and Prospect (2011-2021)
     1.4.3 UK Status and Prospect (2011-2021)
     1.4.4 Russia Status and Prospect (2011-2021)
     1.4.5 Italy Status and Prospect (2011-2021)
     1.4.6 Spain Status and Prospect (2011-2021)
     1.4.7 Benelux Status and Prospect (2011-2021)
  1.5 Europe Market Size (Value and Volume) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (2011-2021)
     1.5.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2021)
     1.5.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2021)2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Manufacturers, Type and Application
  2.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Competition by Manufacturers
     2.1.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share of Key Manufacturers (2015 and 2016)
     2.1.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Share by Manufacturers (2015 and 2016)
  2.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume and Value) by Type
     2.2.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type (2011-2016)
     2.2.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2011-2016)
  2.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume and Value) by Countries
     2.3.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Countries (2011-2016)
     2.3.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Countries (2011-2016)
  2.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume) by Application3 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  3.1 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     3.1.1 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     3.1.2 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     3.1.3 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  3.2 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  3.3 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  3.4 Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application4 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  4.1 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     4.1.1 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     4.1.2 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     4.1.4 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  4.2 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  4.3 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  4.4 France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application5 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  5.1 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     5.1.1 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     5.1.2 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     5.1.5 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  5.2 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  5.3 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  5.4 UK Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application6 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  6.1 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     6.1.1 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     6.1.2 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     6.1.6 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  6.2 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  6.3 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  6.4 Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application7 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  7.1 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     7.1.1 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     7.1.2 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     7.1.7 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  7.2 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  7.3 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  7.4 Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application8 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  8.1 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     8.1.1 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     8.1.2 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     8.1.8 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  8.2 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  8.3 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  8.4 Spain Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application9 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (Volume, Value and Sales Price)
  9.1 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Value (2011-2016)
     9.1.1 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2011-2016)
     9.1.2 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2011-2016)
     9.1.9 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Price Trend (2011-2016)
  9.2 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Manufacturers
  9.3 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type
  9.4 Benelux Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application10 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturers Analysis
  10.1 Janssen
     10.1.1 Company Basic Information, Manufacturing Base and Competitors
     10.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.1.2.1 Type I
         10.1.2.2 Type II
     10.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.1.4 Main Business/Business Overview
  10.2 Qiagen
     10.2.1 Company Basic Information, Manufacturing Base and Competitors
     10.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.2.2.1 Type I
         10.2.2.2 Type II
     10.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.2.4 Main Business/Business Overview
  10.3 Advanced Cell Diagnostics
     10.3.1 Company Basic Information, Manufacturing Base and Competitors
     10.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.3.2.1 Type I
         10.3.2.2 Type II
     10.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.3.4 Main Business/Business Overview
  10.4 ApoCell
     10.4.1 Company Basic Information, Manufacturing Base and Competitors
     10.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.4.2.1 Type I
         10.4.2.2 Type II
     10.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.4.4 Main Business/Business Overview
  10.5 Biofluidica
     10.5.1 Company Basic Information, Manufacturing Base and Competitors
     10.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.5.2.1 Type I
         10.5.2.2 Type II
     10.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.5.4 Main Business/Business Overview
  10.6 Clearbridge Biomedics
     10.6.1 Company Basic Information, Manufacturing Base and Competitors
     10.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.6.2.1 Type I
         10.6.2.2 Type II
     10.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.6.4 Main Business/Business Overview
  10.7 CytoTrack
     10.7.1 Company Basic Information, Manufacturing Base and Competitors
     10.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.7.2.1 Type I
         10.7.2.2 Type II
     10.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.7.4 Main Business/Business Overview
  10.8 Celsee
     10.8.1 Company Basic Information, Manufacturing Base and Competitors
     10.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.8.2.1 Type I
         10.8.2.2 Type II
     10.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.8.4 Main Business/Business Overview
  10.9 Fluxion
     10.9.1 Company Basic Information, Manufacturing Base and Competitors
     10.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.9.2.1 Type I
         10.9.2.2 Type II
     10.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.9.4 Main Business/Business Overview
  10.10 Gilupi
     10.10.1 Company Basic Information, Manufacturing Base and Competitors
     10.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
         10.10.2.1 Type I
         10.10.2.2 Type II
     10.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2011-2016)
     10.10.4 Main Business/Business Overview
  10.11 Cynvenio
  10.12 On-chip
  10.13 YZY Bio
  10.14 BioView
  10.15 Creatv MicroTech
  10.16 Fluidigm
  10.17 Ikonisys
  10.18 AdnaGen
  10.19 IVDiagnostics
  10.20 Miltenyi Biotec
  10.21 Aviva Biosciences Corporation
  10.22 ScreenCell
  10.23 Silicon Biosystems11 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturing Cost Analysis
  11.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Raw Materials Analysis
     11.1.1 Key Raw Materials
     11.1.2 Price Trend of Key Raw Materials
     11.1.3 Key Suppliers of Raw Materials
     11.1.4 Market Concentration Rate of Raw Materials
  11.2 Proportion of Manufacturing Cost Structure
     11.2.1 Raw Materials
     11.2.2 Labor Cost
     11.2.3 Manufacturing Expenses
  11.3 Manufacturing Process Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)12 Industrial Chain, Sourcing Strategy and Downstream Buyers
  12.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industrial Chain Analysis
  12.2